Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Prit Lakhani"'
Autor:
Kai-Wei Wu, Corinne Sweeney, Narendar Dudhipala, Prit Lakhani, Narayan D. Chaurasiya, Babu L. Tekwani, Soumyajit Majumdar
Publikováno v:
AAPS PharmSciTech. 23
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abaee647fbeded14e5480b49265170ac
https://doi.org/10.1208/s12249-021-02171-y
https://doi.org/10.1208/s12249-021-02171-y
Autor:
Babu L. Tekwani, Narendar Dudhipala, Kai-Wei Wu, Prit Lakhani, ND Chaurasiya, Soumyajit Majumdar, Corinne Sweeney
Publikováno v:
AAPS PharmSciTech
Primaquine (PQ), an 8-aminoquinoline antimalarial drug, has been widely used for the eradication of hypnozoites from the liver and, therefore, recognized as the radical cure of malaria. However, the clinical applications of PQ are restricted to patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d1543557760c7e04877613e1f0b84c0
https://europepmc.org/articles/PMC9178661/
https://europepmc.org/articles/PMC9178661/
Autor:
Pranjal Taskar, Soumyajit Majumdar, Mahmoud A. ElSohly, Eman A. Ashour, Goutham R. Adelli, Prit Lakhani, Waseem Gul, Akash Patil
Publikováno v:
Journal of Ocular Pharmacology and Therapeutics. 35:301-310
Purpose: Cannabidiol (CBD), active component of plant Cannabis sativa, has anti-inflammatory properties that could potentially help treat diabetic retinopathy-induced pain and inflammation...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e4cb65581514a8527a017624a751e6d
https://doi.org/10.1089/jop.2018.0141
https://doi.org/10.1089/jop.2018.0141
Publikováno v:
J Drug Deliv Sci Technol
The current study sought to formulate, optimize, and evaluate curcumin-loaded Nanostructured Lipid Carriers (NLCs) for their in vitro and ex vivo characteristics. NLCs, prepared using hot-melt emulsification and ultrasonication techniques, were optim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::727b7bc3af49edabb33bfb79b1378602
https://pubmed.ncbi.nlm.nih.gov/32601526
https://pubmed.ncbi.nlm.nih.gov/32601526
Publikováno v:
J Ocul Pharmacol Ther
Purpose: Natamycin (NTM) ophthalmic suspension is the only FDA-approved formulation commercially available for treating ocular fungal infections. However, precorneal residence times and losses/drainage remain the foremost challenges associated with c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e84c36a528a3a90d0153a71a8fd5b3a8
https://pubmed.ncbi.nlm.nih.gov/32315560
https://pubmed.ncbi.nlm.nih.gov/32315560
Publikováno v:
Therapeutic Delivery. 9:137-153
Over the past decade, there has been a rise in the number of clinical cases of moderate to severe anterior segment ocular diseases. Conventional topical ophthalmic formulations have several limitations – to address which, novel drug-delivery system
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f620e2b5f81b63d69b8b7258fc572c58
https://doi.org/10.4155/tde-2017-0088
https://doi.org/10.4155/tde-2017-0088
Publikováno v:
Journal of Drug Delivery Science and Technology. 41:206-212
Currently, natamycin ophthalmic suspension (Natacyn ® ) is the only commercially available antifungal agent that has been approved in the treatment of superficial fungal infections of the eye such as fungal keratitis, blepharitis, and conjunctivitis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c26467aa3336900494328e198833f5f7
https://doi.org/10.1016/j.jddst.2017.07.015
https://doi.org/10.1016/j.jddst.2017.07.015
Autor:
Siddharth K. Tripathi, Kai-Wei Wu, Shabana I. Khan, Bharathi Avula, Akash Patil, Corinne Sweeney, Prit Lakhani, Soumyajit Majumdar, Pranjal Taskar
Publikováno v:
Int J Pharm
The current study sought to formulate, optimize, and stabilize amphotericin B (AmB) loaded PEGylated nanostructured lipid carriers (NLC) and to study its ocular biodistribution following topical instillation. AmB loaded PEGylated NLC (AmB-PEG-NLC) we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2a70aa80782635711cc0b98ef852f7e
https://pubmed.ncbi.nlm.nih.gov/31669555
https://pubmed.ncbi.nlm.nih.gov/31669555
Autor:
Pranjal S, Taskar, Akash, Patil, Prit, Lakhani, Eman, Ashour, Waseem, Gul, Mahmoud A, ElSohly, Brian, Murphy, Soumyajit, Majumdar
Publikováno v:
Translational Vision Science & Technology
Purpose Δ9-Tetrahydrocannabinol-valine-hemisuccinate, a hydrophilic prodrug of Δ9-tetrahydrocannabinol, synthesized with the aim of improving the ocular bioavailability of the parent molecule, was investigated in a lipid-based nanoparticle dosage f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7581003da6d1c386b4ae72b9f1bc950b
https://pubmed.ncbi.nlm.nih.gov/31588378
https://pubmed.ncbi.nlm.nih.gov/31588378
Autor:
Mittal Darji, Michael A. Repka, Ajinkya M. Bhagurkar, Priyanka Thipsay, Suresh Bandari, Prit Lakhani
Publikováno v:
The Journal of pharmacy and pharmacology. 71(3)
Objectives To investigate the effects of formulation composition on the physico-chemical and drug release properties of mucoadhesive buccal films prepared by melt extrusion technology, using a response surface methodology. Methods Salbutamol sulphate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4da7944cc8a1d38d8bfa0bc92bd6e163
https://pubmed.ncbi.nlm.nih.gov/30485903
https://pubmed.ncbi.nlm.nih.gov/30485903